Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells

Purpose: To investigate the impact of γ-irradiation on cyclooxygenase-2 (COX-2) expression and its enzymatic activity in PC-3 cells. Cell cycle redistribution, viability, and apoptosis were quantitated in control and irradiated cells with or without the COX-2 inhibitor NS-398. Methods and Materials:...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2000-09, Vol.48 (2), p.325-328
Hauptverfasser: Steinauer, Kirsten K, Gibbs, Iris, Ning, Shoucheng, French, John N, Armstrong, Jeff, Knox, Susan J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose: To investigate the impact of γ-irradiation on cyclooxygenase-2 (COX-2) expression and its enzymatic activity in PC-3 cells. Cell cycle redistribution, viability, and apoptosis were quantitated in control and irradiated cells with or without the COX-2 inhibitor NS-398. Methods and Materials: Western blot analysis was used to assess COX-2 protein expression. Prostaglandin (PGE 2) was measured after addition of arachidonic acid (AA) using a Monoclonal Immunoassay Kit. Cell cycle and apoptosis were assessed using flow cytometry. Results: We observed a dose-dependent increase in COX-2 of 37.0%, 79.7%, and 97.5% following irradiation with 5, 10, and 15 Gy, respectively. The PGE 2 level of irradiated cells was higher than in controls (1512 ± 157.5 vs. 973.7 ± 54.2 ρg PGE 2/mL; p < 0.005, n = 4) while cells irradiated in the presence of NS-398 had reduced PGE 2 levels (218.8 ± 80.1 ρg PGE 2/mL; p < 0.005; n = 4). We found no differences in cell cycle distribution or apoptosis between cells irradiated in the presence or absence of NS-398. Conclusions: COX-2 protein is upregulated and enzymatically active after irradiation, resulting in elevated levels of PGE 2. This effect can be suppressed by NS-398, which has clinical implications for therapies combining COX-2 inhibitors with radiation therapy.
ISSN:0360-3016
1879-355X
DOI:10.1016/S0360-3016(00)00671-4